NSE ACCENTMICMain boardPharmaceuticals

Accent Microcell Limited

Pharmaceuticals · Updated 14 Oct 2026

Observed activity7.8/10Higher observable activity
Share price₹678Market cap ₹1,627 Cr

Accent Microcell Limited overview

Digital presence

The official website accentmicrocell.com was reviewed on 14 Oct 2026 and uses HTTPS, is mobile-friendly, has an investor relations section.

A LinkedIn page was found with 2,418 followers and 106 employees listed; 48 posts recorded in the last 90 days, latest 13 Oct 2026.

An Instagram account was found with 309 followers, ~12 posts in the last 90 days, latest 13 Oct 2026.

A Facebook page was found with 972 followers, latest post 13 Oct 2026.

X presence is noted in the research sheet (links and counts not yet recorded).

Information not available

  • Facebook posts in 90 days: not captured
  • YouTube channel: not found

Presence Radar

Reviewed 14 Oct 2026
7.8overallWWebsite7inLinkedIn9IGInstagram7fFacebook6
Website 7LinkedIn 9Instagram 7Facebook 6

Higher observable activity. Colour shows the level of observed activity: higher, moderate, limited. Not a judgement of the company. Methodology v0. How it works

Website checks

✓HTTPSYes
✓Mobile friendlyYes
✓Investor relations sectionPresent
✓Footer copyright year2026
✓Mobile page speed (0–100)53

Social channels

Follower counts can be purchased; shown for reference only.

LinkedIn

9/10
Followers2,418
Employees listed106
Posts, 90 days48
Avg engagement18
Last post13 Oct 2026

linkedin.com/company/accentmicrocellltd

Instagram

7/10
Followers309
Posts, 90 days~12
Avg engagement14
Last post13 Oct 2026

instagram.com/accentmicrocellltd

Facebook

6/10
Followers972
Last post13 Oct 2026

facebook.com/AccentmicrocellLtd

X

Found

Account noted in the research sheet: twitter.com/accentmicrocel1.

Market snapshot prototype data

52-week low
₹253
52-week high
₹732
Price₹678
Market cap₹1,627 Cr
All-time high₹732
Below all-time high7.4%
P/E37.1
Promoter holding51.4%
Dividend yield0.15%

Source: research sheet (14 Oct 2026). Market data still needs a licensed source before public launch.

More in Pharmaceuticals

Prototype data. Details may be incomplete or out of date. Verify with official filings and exchange disclosures.